Negative Inotropic Effects of High Mobility Box Group 1 Protein in Isolated Contracting Cardiac Myocytes

HMGB1 released from necrotic cells or macrophages functions as a late inflammatory mediator, and has been shown to induce cardiovascular collapse during sepsis. Thus far, however, the effect(s) of HMGB1 in the heart are not known. We determined the effects of HMGB1 on isolated feline cardiac myocytes by measuring sarcomere shortening in contracting cardiac myocytes, intracellular Ca 2+ transients using fluo-3, and L-type calcium currents using whole cell perforate configuration of the patch clamp technique. Treatment of isolated myocytes with HMGB1 (100 ng/ml) resulted in a 70% decrease in sarcomere shortening and a 50% decrease in the height of the peak Ca ++ transient within 5 min (p <0.01). The immediate negative inotropic effects HMGB1 on cell contractility and calcium homeostasis were partially reversible upon washout of HMGB1. A significant inhibition of the inward L-type calcium currents also was documented by the patch clamp technique. HMGB1 induced the PKC ε translocation and a PKC inhibitor significantly attenuated the negative inotropic effects of HMGB1. These studies show for the first time that HMGB1 impairs sarcomere shortening by decreasing calcium availability in cardiac myocytes through modulating membrane calcium influx, and suggest that HMGB1 maybe act as a novel myocardial depressant factor during cardiac injury.

[1]  D. Mann,et al.  Targeted gene silencing of tumor necrosis factor attenuates the negative inotropic effects of lipopolysaccharide in isolated contracting cardiac myocytes. , 2008, Texas Heart Institute journal.

[2]  F. Massin,et al.  High-mobility group box 1 protein plasma concentrations during septic shock , 2007, Intensive Care Medicine.

[3]  K. Mani,et al.  The Apoptosis Inhibitor ARC Undergoes Ubiquitin-Proteasomal-mediated Degradation in Response to Death Stimuli , 2007, Journal of Biological Chemistry.

[4]  S. Akira,et al.  Toll-like receptor 2 modulates left ventricular function following ischemia-reperfusion injury. , 2007, American journal of physiology. Heart and circulatory physiology.

[5]  S. Müller,et al.  Exogenous High-Mobility Group Box 1 Protein Induces Myocardial Regeneration After Infarction via Enhanced Cardiac C-Kit+ Cell Proliferation and Differentiation , 2005, Circulation research.

[6]  I. Douglas,et al.  HMGB1 contributes to the development of acute lung injury after hemorrhage. , 2005, American journal of physiology. Lung cellular and molecular physiology.

[7]  K. Tracey,et al.  The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion , 2005, The Journal of experimental medicine.

[8]  P. Rogalla,et al.  Angiogenetic signaling through hypoxia: HMGB1: an angiogenetic switch molecule. , 2005, The American journal of pathology.

[9]  U. Andersson,et al.  RAGE is the Major Receptor for the Proinflammatory Activity of HMGB1 in Rodent Macrophages , 2005, Scandinavian journal of immunology.

[10]  E. Abraham,et al.  Involvement of Toll-like Receptors 2 and 4 in Cellular Activation by High Mobility Group Box 1 Protein* , 2004, Journal of Biological Chemistry.

[11]  K. Tracey,et al.  Reversing established sepsis with antagonists of endogenous high-mobility group box 1 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[12]  A. Sakamoto,et al.  Effect of L-canavanine, an Inhibitor of inducible nitric oxide synthase, on myocardial dysfunction during septic shock. , 2002, Journal of Nippon Medical School = Nippon Ika Daigaku zasshi.

[13]  S. Houser,et al.  Voltage‐dependent Ca2+ release from the SR of feline ventricular myocytes is explained by Ca2+‐induced Ca2+ release , 2000, The Journal of physiology.

[14]  M. Boutjdir,et al.  Evidence for functional role of epsilonPKC isozyme in the regulation of cardiac Ca(2+) channels. , 2000, American journal of physiology. Heart and circulatory physiology.

[15]  K. Tracey,et al.  HMG-1 as a late mediator of endotoxin lethality in mice. , 1999, Science.

[16]  A. Harken,et al.  Tumor necrosis factor-alpha and interleukin-1beta synergistically depress human myocardial function. , 1999, Critical care medicine.

[17]  Anand Kumar,et al.  Role of nitric oxide and cGMP in human septic serum-induced depression of cardiac myocyte contractility. , 1999, American journal of physiology. Regulatory, integrative and comparative physiology.

[18]  C. Szabó,et al.  Proinflammatory cytokines depress cardiac efficiency by a nitric oxide-dependent mechanism. , 1998, American journal of physiology. Heart and circulatory physiology.

[19]  W. Lew,et al.  Depyrogenation of digestive enzymes reduces lipopolysaccharide tolerance in isolated cardiac myocytes. , 1997, Journal of molecular and cellular cardiology.

[20]  W. Schmitz,et al.  Endotoxin and cytokines induce direct cardiodepressive effects in mammalian cardiomyocytes via induction of nitric oxide synthase. , 1996, Journal of molecular and cellular cardiology.

[21]  T. McKenna,et al.  PKC mediates LPS- and phorbol-induced cardiac cell nitric oxide synthase activity and hypocontractility. , 1995, The American journal of physiology.

[22]  M. Fink,et al.  Load-insensitive assessment of myocardial performance after tumor necrosis factor-alpha in dogs. , 1992, Surgery.

[23]  B. Parsons,et al.  Adrenergic Effects on the Biology of the Adult Mammalian Cardiocyte , 1992, Circulation.

[24]  F. Ognibene,et al.  Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. , 1990, Annals of internal medicine.

[25]  C. Natanson,et al.  Role of endotoxemia in cardiovascular dysfunction and mortality. Escherichia coli and Staphylococcus aureus challenges in a canine model of human septic shock. , 1989, The Journal of clinical investigation.

[26]  R. E. Shepherd,et al.  The effect of in vivo endotoxin on myocardial function in vitro. , 1986, Circulatory shock.

[27]  H. Adams,et al.  Isolated cardiac preparations: models of intrinsic myocardial dysfunction in circulatory shock. , 1985, Circulatory shock.